$TPIV..$.38..Folate Alpha Receptor Info. This is the new target being looked at by Dr. Edith Perez of the Mayo Clinic as she will head up the Phase 2 clinical trial for $TPIV triple negative breast trial. http://www.archivesofpathology.org/doi/pdf/10.5858/arpa.2013-0309-OA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.